Posterior Reversible Encephalopathy Syndrome after Heart Transplantation: Diagnosis and Immunosuppressive Therapy
- PMID: 28761402
- PMCID: PMC5505400
- DOI: 10.14503/THIJ-15-5007
Posterior Reversible Encephalopathy Syndrome after Heart Transplantation: Diagnosis and Immunosuppressive Therapy
Abstract
Posterior reversible encephalopathy syndrome, an infrequent neurotoxicity associated with the use of tacrolimus, was first described in 1996, as a reversible syndrome manifested by headache, altered mental function, seizures, and visual disturbances. We describe the case of a 37-year-old woman who developed neurologic symptoms consistent with encephalopathy after treatment with tacrolimus, which was prescribed to maintain immunosuppression after orthotopic heart transplantation. This report also discusses the imaging methods used in the diagnosis of posterior reversible encephalopathy and highlights the difficulty of maintaining immunosuppression and managing medication-related adverse effects, while taking into account the risk of acute rejection after transplantation.
Keywords: Brain diseases/diagnostic imaging; drug therapy, combination; graft rejection/heart transplantation/adverse effects; immunosuppressive agents/therapeutic use; nervous system diseases/chemically induced; tacrolimus/adverse effects/therapeutic use; treatment outcome.
Figures



Similar articles
-
Alternative tacrolimus and sirolimus regimen associated with rapid resolution of posterior reversible encephalopathy syndrome after lung transplantation.Pediatr Neurol. 2014 Mar;50(3):272-5. doi: 10.1016/j.pediatrneurol.2013.11.006. Epub 2013 Nov 16. Pediatr Neurol. 2014. PMID: 24405697
-
Posterior Reversible Encephalopathy Syndrome After Orthotopic Heart Transplantation: A Case Report.Am J Case Rep. 2017 May 3;18:487-490. doi: 10.12659/ajcr.903403. Am J Case Rep. 2017. PMID: 28465499 Free PMC article.
-
Tacrolimus-associated ischemic optic neuropathy and posterior reversible encephalopathy syndrome after small bowel transplantation.Transplantation. 2012 Nov 15;94(9):e58-60. doi: 10.1097/TP.0b013e31826dde21. Transplantation. 2012. PMID: 23128973 No abstract available.
-
Sirolimus-Induced Combined Posterior Reversible Encephalopathy Syndrome and Lymphocytic Pneumonitis in a Renal Transplant Recipient: Case Report and Review of the Literature.Exp Clin Transplant. 2017 Feb;15(Suppl 1):170-174. doi: 10.6002/ect.mesot2016.P36. Exp Clin Transplant. 2017. PMID: 28260460 Review.
-
Tacrolimus-associated posterior reversible encephalopathy syndrome after solid organ transplantation.Eur Neurol. 2010;64(3):169-77. doi: 10.1159/000319032. Epub 2010 Aug 12. Eur Neurol. 2010. PMID: 20699617 Review.
Cited by
-
Clinical features and outcomes of posterior reversible encephalopathy syndrome after heart transplantation: a case series.Clin Transplant Res. 2024 Jun 30;38(2):154-162. doi: 10.4285/ctr.24.0009. Epub 2024 Jun 24. Clin Transplant Res. 2024. PMID: 38910457 Free PMC article.
-
Tacrolimus-Induced Neurotoxicity After Transplant: A Literature Review.Drug Saf. 2024 May;47(5):419-438. doi: 10.1007/s40264-024-01398-5. Epub 2024 Feb 14. Drug Saf. 2024. PMID: 38353884 Review.
-
Fatal PRES and super-refractory status epilepticus after combined heart and kidney transplant: A case report and literature review.JHLT Open. 2024 Mar 2;4:100078. doi: 10.1016/j.jhlto.2024.100078. eCollection 2024 May. JHLT Open. 2024. PMID: 40144232 Free PMC article. Review.
-
A Case of Antibiotic-Induced Posterior Reversible Encephalopathy Syndrome.Hosp Pharm. 2020 Oct;55(5):338-341. doi: 10.1177/0018578719844706. Epub 2019 May 9. Hosp Pharm. 2020. PMID: 32999504 Free PMC article.
-
Posterior Reversible Encephalopathy Syndrome Associated with Tacrolimus in Cardiac Transplantation.Case Rep Cardiol. 2021 Jun 24;2021:9998205. doi: 10.1155/2021/9998205. eCollection 2021. Case Rep Cardiol. 2021. PMID: 34258073 Free PMC article.
References
-
- Kou R, Greif D, Michel T.. Dephosphorylation of endothelial nitric-oxide synthase by vascular endothelial growth factor. Implications for the vascular responses to cyclosporin A. J Biol Chem 2002; 277 33: 29669– 73. - PubMed
-
- Baran DA, Zucker MJ, Arroyo LH, Camacho M, Goldschmidt ME, Nicholls SJ, . et al. A prospective, randomized trial of single-drug versus dual-drug immunosuppression in heart transplantation: the tacrolimus in combination, tacrolimus alone compared (TICTAC) trial. Circ Heart Fail 2011; 4 2: 129– 37. - PubMed
-
- Colombo D, Ammirati E.. Cyclosporine in transplantation - a history of converging timelines. J Biol Regul Homeost Agents 2011; 25 4: 493– 504. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical